Yu-Hsin Tseng

14PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMolecular targetsPharmacogenomicsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 21, 2026
Corylin Confers Vasoprotection via JDP2-Nrf2 Antioxidant Axis against Chronic Kidney Disease-Induced Smooth Muscle Cell Remodelling.

|Jun 26, 2026
Salivary CD5L as a Potential Non-Invasive Biomarker for Pathological Staging and Prognostic Assessment in Oral Squamous Cell Carcinoma.

|Apr 23, 2026
Andrographolide Modulates Fibrogenic and Oxidative Stress Responses in Human Lung Fibroblasts.

|Mar 14, 2026
The Clinical Significance of SPOP Upregulation and Nuclear Accumulation in Head and Neck Squamous Cell Carcinoma.

Yin-Hwa Shih, Nan-Chin Lin, Yen-Wen Shen

|Apr 29, 2024
Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells.

Yi-Ching Liu, Yu-Hsin Tseng, Yu-Hsin Kuan

|May 14, 2022
Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis.

I-Chen Chen, Yi-Ching Liu, Yen-Hsien Wu

Pageof 3

Frequent Collaborators

4 joint publications

Tzong-Ming Shieh

3 joint publications

Jong-Hau Hsu

3 joint publications

I-Chen Chen

2 joint publications

Shih-Min Hsia